A leading vaccine company required rapid growth in response to global Covid-19 pandemic.
A leading US based vaccine biotech company was urgently working to establish a Covid-19 vaccine in response to the global pandemic that began in March 2020. This involved the growth of the company across all areas of R&D. We had a historical relationship with this organisation, but with the onset of the pandemic, they connected with a senior member of our New York office to help oversee a series of hires from VP level down.
We deployed specialist dedicated delivery teams based on the East Coast, with a single point of contact working alongside the existing TA team to supplement the extra hiring demand. We acted as an extension to the TA team, creating candidate trackers, scheduling interviews and keeping a close relationship with key stakeholders.